There’s a very old saying that’s all fair in love and war, but whoever said that never meet a pharmaceutical rep. Although there aren’t as many as there used to be reps can play a pivotal role when it comes to launching a new drug. There is no question that formulary position is a critical piece of the puzzle and that reps have less access to physicians than ever but still they do play a role. The upcoming launch of Rybelsus® the oral GLP-1 from Novo Nordisk will put this role to the test.
As we . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.